1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Pre- and Postoperative Antioxidant Use, Aryl Hydrocarbon Receptor (AhR) Activation and Clinical Outcome in Different Treatment Groups of Breast Cancer Patients
(
- Contribution to journal › Article
- 2023
-
Mark
Circulating tumour HPV16 DNA quantification – A prognostic tool for progression-free survival in patients with HPV-related oropharyngeal carcinoma receiving curative chemoradiotherapy
(
- Contribution to journal › Article
-
Mark
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response
(
- Contribution to journal › Article
-
Mark
Effect of Conventional and Ultrahigh Dose Rate FLASH Irradiations on Preclinical Tumor Models : A Systematic Analysis
(
- Contribution to journal › Article
-
Mark
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors
(
- Contribution to journal › Article
- 2022
-
Mark
In vitro assays for investigating the FLASH effect
(
- Contribution to journal › Scientific review
-
Mark
Development of dosimetric procedures for experimental ultra-high dose rate irradiation at a clinical linear accelerator
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Research Paper Impact of combining vitamin C with radiation therapy in human breast cancer : Does it matter?
(
- Contribution to journal › Article
-
Mark
Comment on Russo et al. Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis. Cancers 2022, 14, 2465
(
- Contribution to journal › Letter
-
Mark
Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model
(
- Contribution to journal › Article